Neurohormonal mechanisms and the role of angiotensin-converting enzyme (ACE) inhibitors in heart failure Andrew J. S. CoatsS. Adamopoulos Review Pages: 685 - 692
Regression of left ventricular hypertrophy and improvement of renal hemodynamics in hypertensive patients treated with quinapril L. De CaprioM. L. De RosaF. Rengo Hypertension Pages: 735 - 740
Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease Wataru HayashidaChristian van EyllHubert Pouleur Ischemic Heart Disease Pages: 741 - 747
Blockade of ATP-sensitive potassium channels by 5-hydroxydecanoate suppresses monophasic action potential shortening during regional myocardial ischemia Kazunori MoritaniToshihisa MiyazakiSatoshi Ogawa Potassium Channels Pages: 749 - 756
J curve in antihypertensive therapy—Does it exist? A personal point of view J. M. Cruickshank State-Of-The-Art Lectures Pages: 757 - 760
Reassessment of digoxin and other low-dose positive inotropes in the treatment of chronic heart failure Jason TaukeDiana HanMihai Gheorghiade State-Of-The-Art Lectures Pages: 761 - 768
Amiodarone as a first-line drug in the treatment of atrial fibrillation: The protagonist viewpoint Samuel Lévy State-Of-The-Art Lectures Pages: 769 - 771
Low-dose amiodarone should not be the first-line treatment for atrial fibrillation Ruey J. Sung State-Of-The-Art Lectures Pages: 773 - 774
Peripheral vein plasma endothelin-1 levels during coronary angioplasty increase only in normotensive patients Zenon S. KyriakidesManolis MarkianosDimitrios T. Kremastinos Letter To The Editor Pages: 775 - 777
